Literature DB >> 11481689

Corticobasal syndrome with tau pathology.

N J Cordato1, G M Halliday, H McCann, L Davies, P Williamson, M Fulham, J G Morris.   

Abstract

Six cases with a clinical corticobasal syndrome (progressive asymmetric apraxia and parkinsonism unresponsive to levodopa) and tau pathology were selected from 97 brain donors with parkinsonism. Postmortem volumetric measures of regional brain atrophy (compared with age/sex-matched controls) were correlated with clinical features and the degree of underlying cortical and subcortical histopathology. At death, no significant asymmetry of pathology was detected. All cases had prominent bilateral atrophy of the precentral gyrus (reduced by 22-54%) with other cortical regions variably affected. Subcortical atrophy was less severe and variable. Two cases demonstrated widespread atrophy of basal ganglia structures (44-60% atrophy of the internal globus pallidus) and substantial subcortical pathology consistent with a diagnosis of progressive supranuclear palsy (PSP). The remaining four cases had typical pathology of corticobasal degeneration. In all cases, neuronal loss and gliosis corresponded with subcortical atrophy, while the density of cortical swollen neurons correlated with cortical volume loss. Atrophy of the internal globus pallidus was associated with postural instability, while widespread basal ganglia histopathology was found in cases with gaze palsy. This study confirms the involvement of the precentral gyrus in the corticobasal syndrome and highlights the variable underlying pathology in these patients. Copyright 2001 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481689     DOI: 10.1002/mds.1124

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

Review 1.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

Review 2.  Ocular motor abnormalities in neurodegenerative disorders.

Authors:  C A Antoniades; C Kennard
Journal:  Eye (Lond)       Date:  2014-11-21       Impact factor: 3.775

3.  Progressive apraxic agraphia with micrographia presenting as corticobasal syndrome showing extensive Pittsburgh compound B uptake.

Authors:  Yasuhisa Sakurai; Kenji Ishii; Masahiro Sonoo; Yuko Saito; Shigeo Murayama; Atsushi Iwata; Kensuke Hamada; Izumi Sugimoto; Shoji Tsuji; Toru Mannen
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

4.  Impairment of intermediate somatosensory function in corticobasal syndrome.

Authors:  Kana Matsuda; Masayuki Satoh; Ken-Ichi Tabei; Yukito Ueda; Akira Taniguchi; Keita Matsuura; Masaru Asahi; Yuichiro Ii; Atsushi Niwa; Hidekazu Tomimoto
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

Review 5.  How to spot ocular abnormalities in progressive supranuclear palsy? A practical review.

Authors:  Onanong Phokaewvarangkul; Roongroj Bhidayasiri
Journal:  Transl Neurodegener       Date:  2019-07-10       Impact factor: 8.014

6.  Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).

Authors:  Yuya Saito; Koji Kamagata; Peter A Wijeratne; Christina Andica; Wataru Uchida; Kaito Takabayashi; Shohei Fujita; Toshiaki Akashi; Akihiko Wada; Keigo Shimoji; Masaaki Hori; Yoshitaka Masutani; Daniel C Alexander; Shigeki Aoki
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.086

Review 7.  Neuropathology and emerging biomarkers in corticobasal syndrome.

Authors:  Shunsuke Koga; Keith A Josephs; Ikuko Aiba; Mari Yoshida; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-06-13       Impact factor: 13.654

Review 8.  Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.

Authors:  Zuzana Walker; Federica Gandolfo; Stefania Orini; Valentina Garibotto; Federica Agosta; Javier Arbizu; Femke Bouwman; Alexander Drzezga; Peter Nestor; Marina Boccardi; Daniele Altomare; Cristina Festari; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-19       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.